Healthcare >> CEO Interviews >> January 22, 2014

Interview with the President, CEO and Director: Enanta Pharmaceuticals, Inc. (ENTA)

Luly, Jay R.
Jay R. Luly, Ph.D., is President, Chief Executive Officer and Director of Enanta Pharmaceuticals, Inc. Dr. Luly joined Enanta in July 2003. Prior to joining Enanta, he was an Entrepreneur in Residence at Oxford Bioscience Partners. Before joining Oxford in March 2002, Dr. Luly held the positions of Senior Vice President, Research and Development Operations, and Senior Vice President, Discovery Strategy and Operations at Millennium Pharmaceuticals, following Millennium’s merger with LeukoSite, Inc., where he had served as Senior Vice President, Drug Discovery and Preclinical Development. Prior to joining LeukoSite, he held a number of senior drug discovery positions at Abbott Laboratories from 1983 to 1997. Profile
TWST: I'd like to start with a brief overview of Enanta's business.

Dr. Luly: Enanta is a biotechnology company focused on infectious disease, and we have a particular focus on